(Q41456132)

30 September 2017

title

Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action (English)

1 reference

30 September 2017

0 references

1 reference

Yosef Rosenfeld

1

1 reference

30 September 2017

Niv Papo

series ordinal

2

1 reference

30 September 2017

Yechiel Shai

series ordinal

3

1 reference

30 September 2017

language of work or name

English

0 references

publication date

17 November 2005

1 reference

Journal of Biological Chemistry

30 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

30 September 2017

volume

281

1 reference

30 September 2017

issue

3

1 reference

30 September 2017

page(s)

1636-1643

1 reference

Lipopolysaccharide endotoxins

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

The role of antimicrobial peptides in animal defenses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Toll receptors, CD14, and macrophage activation and deactivation by LPS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

The immunopathogenesis of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Structure and function of lipopolysaccharide binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Lipopolysaccharide binding protein and CD14 in LPS dependent macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Molecular mechanisms of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Towards a rational development of anti-endotoxin agents: novel approaches to sequestration of bacterial endotoxins with small molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Novel therapies for sepsis: antiendotoxin therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Peptide antibiotics and their role in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Antimicrobial peptides of multicellular organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Potential therapeutic role of cationic peptides in three experimental models of septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

The role of polar and facial amphipathic character in determining lipopolysaccharide-binding properties in synthetic cationic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Interaction of D-amino acid incorporated analogues of pardaxin with membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Analysis of lipopolysaccharide (LPS)-binding characteristics of serum components using gel filtration of FITC-labeled LPS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Use of helical wheels to represent the structures of proteins and to identify segments with helical potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Membrane insertion and lateral diffusion of fluorescence-labelled cytochrome c oxidase subunit IV signal peptide in charged and uncharged phospholipid bilayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Exploring peptide membrane interaction using surface plasmon resonance: differentiation between pore formation versus membrane disruption by lytic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Bacterial lipopolysaccharides and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

Biophysical characterization of endotoxin inactivation by NK-2, an antimicrobial peptide derived from mammalian NK-lysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M504327200

21 January 2018

Identifiers

DOI

10.1074/JBC.M504327200

1 reference

30 September 2017

1 reference